GlobalRPh RX List - SANDOSTATIN injection
- Product / population
- SANDOSTATIN immediate-release octreotide injection; not LAR DEPOT or oral octreotide.
- Renal measure
- Qualitative renal finding; no numerical adjustment threshold inferred.
RX mirror: this is not independent corroboration of its underlying label. Check dated-label and formulation limitations.
Renal dosing, restrictions and evidence limits
Severe renal failure requiring dialysis can prolong the half-life, so the maintenance dosage may need adjustment. The selected immediate-release injection source supplies no fixed percentage reduction or complete numerical dialysis schedule. Reduced clearance in dialysis is a pharmacokinetic observation, not an instruction to halve every dose. Keep this product separate from SANDOSTATIN LAR DEPOT and oral octreotide; their renal initiation instructions cannot be transferred to this injection.